Microbix Presents Molecular Pathology Platform Results
MBX Biosciences, Inc.MBX Biosciences, Inc.(US:MBX) Accessnewswire·2026-02-04 12:00

Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of its novel Quality Assessment Products ("QAPsâ"¢") and platform technology for supporting the quality management and reproducibility of Molecular Pathology derived diagnoses of infectious diseases at Labquality Days, a lab diagno ...